Johnson & Johnson
Change company Symbol lookup
Select an option...
JNJ Johnson & Johnson
RBCAA Republic Bancorp Inc
IMTE Integrated Media Technology Ltd
GECC Great Elm Capital Corp
SCX L S Starrett Co
VFIAX Vanguard 500 Index Fund Admiral Shares
ONCT Oncternal Therapeutics Inc
BBRW Brewbilt Manufacturing Inc
AMOT Allied Motion Technologies Inc
AAPL Apple Inc
Go

Health Care : Pharmaceuticals | Large Cap Value
Company profile

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the baby care, oral care, skin care, over-the-counter pharmaceutical, women's health and wound care markets. The Pharmaceutical segment is focused on five therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment includes a range of products used in the orthopedic, surgery, cardiovascular, diabetes care and vision care fields. Its research facilities are located in the United States, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Japan, the Netherlands, Singapore, Switzerland and the United Kingdom.

Closing Price
$142.85
Day's Change
-0.13 (-0.09%)
Bid
--
Ask
--
B/A Size
--
Day's High
143.97
Day's Low
141.23
Volume
(Below Average)
Volume:
5,622,609

10-day average volume:
6,893,863
5,622,609

Display:

Providers:

UpdateCancel
6 providers
Today's News, July 07, 2020
New Innovative Brands Look to Disrupt big Tobacco With Better-for-you Alternatives

Tobacco use has continued to grow steadily since its humble beginnings, fueled by the mass marketing of cigarettes in the 20th century. Nowadays, however, the tobacco industry's growth has been abated by growing knowledge about the inherent health...(PR Newswire)

Yesterday's News, July 06, 2020
Stop TB Partnership and Johnson & Johnson, with support from USAID and The Global Fund, Announce Price Reduction for SIRTURO(R) (bedaquiline) for Treatment of Drug-Resistant Tuberculosis in Low- and Middle-Income Countries

The Stop TB Partnership and Johnson & Johnson (NYSE: JNJ) - with support from the Global Fund to Fight AIDS, TB and Malaria, and the U.S. Agency for International Development (USAID) - today announced joint efforts to help enable low- and...(PR Newswire)

June 24, 2020
Psychedelic Drugs Market Projected to Reach $6.85 Billion by 2027

The psychedelic drugs market is projected to grow at a CAGR of 16.3% over the next eight years to reach $6.85 billion by 2027, according to Data Bridge Market Research. The key factors that will fuel this growth include the increasing prevalence of...(PR Newswire)

June 18, 2020
Are Antivirals For COVID-19 More Likely to Be Developed and Approved Before a Vaccine

Now that confirmed worldwide cases of the global health crisis are continuing to grow, scientists are pushing forward with efforts to develop vaccines and treatments to slow the pandemic and lessen the disease's damage. Scientists around the world...(PR Newswire)

June 10, 2020
Johnson & Johnson Announces Acceleration of its COVID-19 Vaccine Candidate; Phase 1/2a Clinical Trial to Begin in Second Half of July

Johnson & Johnson (NYSE: JNJ) (the Company) today announced that through its Janssen Pharmaceutical Companies (Janssen) it has accelerated the initiation of the Phase 1/2a first-in-human clinical trial of its investigational SARS-CoV-2 vaccine...(PR Newswire)

June 08, 2020
Psychedelic-derived Therapies are Just What the Doctor Ordered to Address a Historic Mental Illness Epidemic

While the global death toll caused by the pandemic is well-publicized, a lesser-known side effect of the ongoing pandemic is the historic rise in mental illness that it has generated. Due to the stress, suffering, and isolation caused by the...(PR Newswire)

June 05, 2020
Innovative Wearable Devices Grant Healthcare Practitioners Greater Flexibility

Now that concerns from the pandemic are receding, states have begun to re-open and businesses are planning for a return to work. However, many employers are facing a challenge: determining how to create a safe work environment for employees while...(PR Newswire)

June 04, 2020
Johnson & Johnson to Host Annual Health for Humanity Investor Webcast

Johnson & Johnson (NYSE: JNJ), the world's largest and most broadly-based healthcare company, announced today it will host a Health for Humanity investor webcast at 8:00 a.m. Eastern Time on June 18, 2020. The webcast will highlight Johnson...(PR Newswire)

June 02, 2020
Psychedelic Drugs Could Potentially Treat Impending Post-lockdown Mental Health Epidemic

Trials are already underway testing the use of psychedelics such as psilocybin, LSD, ketamine, ecstasy and other currently scheduled drugs to treat a mental health epidemic predicted to hit after the lockdown is over. New research in the USA is also...(PR Newswire)

May 28, 2020
Johnson & Johnson to Participate in the Goldman Sachs 41st Annual Global Virtual Healthcare Conference

Johnson & Johnson (NYSE: JNJ) will participate in the Goldman Sachs 41st Annual Global Virtual Healthcare Conference on Tuesday, June 10. Jennifer Taubert, Executive Vice President, Worldwide Chairman Pharmaceuticals will represent the Company...(PR Newswire)

May 19, 2020
Attorney Mark Lanier 'Gratified but Not Yet Satisfied' by Johnson & Johnson Decision to Discontinue Talc-Based Baby Powder

Mark Lanier, the trial lawyer who earned the largest jury verdict to date on behalf of consumers who have developed cancer from talc-based cosmetics, welcomed an announcement by Johnson & Johnson (NYSE: JNJ) that it would cease manufacturing...(PR Newswire)

May 18, 2020
Johnson & Johnson to Provide Webcast Fireside Chat on Clinical Data to be Presented at the American Society of Clinical Oncology and the Janssen Oncology Strategy and Portfolio

The Janssen Pharmaceutical Companies of Johnson & Johnson (NYSE: JNJ) will participate in a pre-recorded fireside chat webcast hosted by Cantor Fitzgerald focused on clinical data being presented at the virtual 2020 American Society of Clinical...(PR Newswire)

May 12, 2020
Former Head of Johnson and Johnson Ukraine to Join Electromedical Technologies, Inc. Marketing Advisory Board

Electromedical Technologies, Inc. (OTC: ELCQ) (the "Company"), a pioneer in the development and manufacturing of bioelectronic devices, including the FDA cleared WellnessPro(R), designed to relieve chronic, intractable and acute pains by using...(BusinessWire)

May 07, 2020
Magic Mushrooms Could Be the Next Investment Trend

With the market surging back to life, investors are poised to pounce on the next trend. And if you missed out on the biotech boom then you'll want to pay special attention to what's coming next. Mentioned in today's market commentary: Pfizer Inc...(PR Newswire)

April 27, 2020
Federal Judge Excludes Certain Plaintiff Expert Testimony from Talc Ovarian Cancer Trials, Deeming Them Not Scientifically Sound

Johnson & Johnson ("the Company") (NYSE: JNJ) today announced that U.S. District Judge Freda L. Wolfson, chief judge of the District of New Jersey, who is presiding over the federal multidistrict litigation (MDL) involving claims that Johnson's...(PR Newswire)

April 23, 2020
Johnson & Johnson Announces Collaboration to Expand Manufacturing Capabilities For its COVID-19 Vaccine Candidate in Support of the Company's Goal to Supply More Than One Billion Vaccine Doses Globally

Johnson & Johnson (the Company) (NYSE: JNJ) today announced a collaboration between the Janssen Pharmaceutical Companies of Johnson & Johnson and Emergent BioSolutions, Inc. to support the manufacturing of its lead investigational COVID-19...(PR Newswire)

April 20, 2020
Thinking about trading options or stock in Edwards Lifesciences, Johnson & Johnson, Procter & Gamble, Roku, or Shopify?

InvestorsObserver issues critical PriceWatch Alerts for EW, JNJ, PG, ROKU, and SHOP. https://mma.prnewswire.com/media/1086590/InvestorsObserver_Logo.jpg Click a link below then choose between in-depth options trade idea report or a stock score...(PR Newswire)

April 15, 2020
Thinking about trading options or stock in Alibaba, Johnson & Johnson, Teladoc Health, Target, or Zoom Video Communications?

InvestorsObserver issues critical PriceWatch Alerts for BABA, JNJ, TDOC, TGT, and ZM. https://mma.prnewswire.com/media/1086590/InvestorsObserver_Logo.jpg Click a link below then choose between in-depth options trade idea report or a stock score...(PR Newswire)

April 14, 2020
Johnson & Johnson Reports 2020 First-Quarter Results

Johnson & Johnson (NYSE: JNJ) today announced results for first-quarter 2020. The Company also announced earlier today that its Board of Directors declared a 6.3% increase in the quarterly dividend rate, from $0.95 per share to $1.01 per share...(PR Newswire)

Johnson & Johnson Announces Dividend Increase of 6.3%

Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a 6.3% increase in the quarterly dividend rate, from $0.95 per share to $1.01 per share. "In recognition of our 2019 results, strong financial position and...(PR Newswire)

Next >

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.